Literature DB >> 18499694

Clinical implications of idiopathic multicentric castleman disease among Japanese: a report of 28 cases.

Masaru Kojima1, Naoya Nakamura, Norihumi Tsukamoto, Yoshiro Otuski, Kazuhiko Shimizu, Hideaki Itoh, Satsuki Kobayashi, Hiroshi Kobayashi, Takuhei Murase, Nobuhide Masawa, Makoto Kashimura, Shigeo Nakamura.   

Abstract

To clarify the clinicopathologic findings of idiopathic multicentric Castleman disease among Japanese, 28 cases were studied. Two variants were delineated by the clinicopathologic findings (1) idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia (n = 18) and (2) nonidiopathic plasmacytic lymphadenopathy type (n= 10). Clinicopathologically, idiopathic plasmacytic lymphadenopathy was defined by the prominent polyclonal hyperimmunoglobulinemia, normal germinal centers, and sheet-like infiltration of plasma cells in the interfollicular area of the lymph node. Histologically, the nonidiopathic plasmacytic lymphadenopathy type was characterized by hyaline-vascular germinal centers of the lymph node lesion. In comparison with idiopathic plasmacytic lymphadenopathy, patients with nonidiopathic plasmacytic lymphadenopathy showed infrequent prominent polyclonal hyperimmunoglobulinemia and frequent association with autoimmune disease. However, there was no difference in the overall 5-year survival between the 2 subtypes. Compared with idiopathic multicentric Castleman disease in Western countries, the chronic course of the disease of idiopathic multicentric Castleman disease in Japan appears to be related to negativity for human herpesvirus 8 infection.

Entities:  

Mesh:

Year:  2008        PMID: 18499694     DOI: 10.1177/1066896908315812

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  24 in total

1.  Budd-Chiari syndrome, a rare complication of multicentric Castleman disease: A case report.

Authors:  Kui Song; Min Li
Journal:  Oncol Lett       Date:  2015-03-03       Impact factor: 2.967

Review 2.  Multicentric Castleman disease: Where are we now?

Authors:  Hao-Wei Wang; Stefania Pittaluga; Elaine S Jaffe
Journal:  Semin Diagn Pathol       Date:  2016-05-16       Impact factor: 3.464

3.  Clinicopathological Profile of Castleman's Disease in Indian Population: Experience From a Tertiary Care Center.

Authors:  Ashok Singh; Suvendu Purkait; Saumyaranjan Mallick; Prashant Ramteke; Chandan Krushna Das; Ajay Gogia; Maher Chand Sharma; Lalit Kumar
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-25       Impact factor: 0.900

4.  Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

Authors:  Yasufumi Masaki; Hiroshi Kawabata; Kazue Takai; Masaru Kojima; Norifumi Tsukamoto; Yasuhito Ishigaki; Nozomu Kurose; Makoto Ide; Jun Murakami; Kenji Nara; Hiroshi Yamamoto; Yoko Ozawa; Hidekazu Takahashi; Katsuhiro Miura; Tsutomu Miyauchi; Shinichirou Yoshida; Akihito Momoi; Nobuyasu Awano; Soichiro Ikushima; Yasunori Ohta; Natsue Furuta; Shino Fujimoto; Haruka Kawanami; Tomoyuki Sakai; Takafumi Kawanami; Yoshimasa Fujita; Toshihiro Fukushima; Shigeo Nakamura; Tomohiro Kinoshita; Sadao Aoki
Journal:  Int J Hematol       Date:  2016-03-18       Impact factor: 2.490

5.  Liver cirrhosis in a child associated with Castleman's disease: A case report.

Authors:  Soya Kobayashi; Ayano Inui; Tomoyuki Tsunoda; Syuichiro Umetsu; Tsuyoshi Sogo; Masaaki Mori; Masato Shinkai; Tomoo Fujisawa
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

Review 6.  Castleman disease.

Authors:  Antonino Carbone; Margaret Borok; Blossom Damania; Annunziata Gloghini; Mark N Polizzotto; Raj K Jayanthan; David C Fajgenbaum; Mark Bower
Journal:  Nat Rev Dis Primers       Date:  2021-11-25       Impact factor: 65.038

7.  Hyaline vascular castleman disease involving renal parenchyma and a lymph node: a case report.

Authors:  Ji Hyun Kwon; Soo Kee Min; Mi Kyung Shin; Yong Seong Lee; Young-Goo Lee; Young Hyeh Ko
Journal:  Korean J Pathol       Date:  2012-02-23

Review 8.  IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease.

Authors:  Mukul Divatia; Sun A Kim; Jae Y Ro
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

9.  Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review.

Authors:  Elizaveta Belyaeva; Ayelet Rubenstein; Sheila K Pierson; Delaney Dalldorf; Dale Frank; Megan S Lim; David C Fajgenbaum
Journal:  Hematol Oncol       Date:  2022-02-18       Impact factor: 4.850

10.  The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.

Authors:  Ikuko Kubokawa; Akihiro Yachie; Akira Hayakawa; Satoshi Hirase; Nobuyuki Yamamoto; Takeshi Mori; Tomoko Yanai; Yasuhiro Takeshima; Eiryu Kyo; Goichi Kageyama; Hiroshi Nagai; Keiichiro Uehara; Masaru Kojima; Kazumoto Iijima
Journal:  BMC Pediatr       Date:  2014-06-02       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.